Pneumococcal Vaccine
Support for Indigenous Development of 16-Valent Pneumococcal Vaccine
The Technology Development Board (TDB) of India has provided financial support to TechInvention Lifecare Ltd. for establishing a commercial-scale facility to produce a 16-valent Pneumococcal Conjugate Vaccine (PCV-16). This initiative aims to enhance India's vaccine manufacturing capabilities, reduce reliance on imports, and improve public health by targeting specific